GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $83.66 $93.35 Wednesday, 17th Apr 2024 BMRN stock ended at $90.47. This is 0.440% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 1.67% from a day low at $90.02 to a day high of $91.53.
90 days $83.44 $94.51
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2023-04-19 $98.40 $99.51 $98.13 $99.06 962 938
2023-04-18 $100.25 $100.31 $98.11 $98.41 759 094
2023-04-17 $99.55 $100.38 $98.83 $100.30 881 152
2023-04-14 $98.40 $99.18 $98.06 $99.01 841 727
2023-04-13 $97.31 $98.98 $97.31 $98.34 1 039 282
2023-04-12 $99.00 $99.45 $97.85 $97.96 862 626
2023-04-11 $98.06 $98.82 $97.48 $97.84 1 026 892
2023-04-10 $99.56 $99.66 $97.28 $98.05 885 527
2023-04-06 $96.28 $99.80 $95.75 $99.60 1 486 600
2023-04-05 $95.99 $96.99 $95.47 $96.57 1 072 242
2023-04-04 $96.80 $96.86 $95.13 $95.43 946 542
2023-04-03 $97.09 $97.42 $96.46 $96.60 881 347
2023-03-31 $95.57 $97.70 $95.56 $97.24 1 434 386
2023-03-30 $94.45 $95.89 $94.34 $95.29 1 226 528
2023-03-29 $91.89 $94.45 $91.39 $94.20 1 072 586
2023-03-28 $91.23 $92.10 $90.81 $91.44 859 877
2023-03-27 $91.50 $92.10 $91.10 $91.50 1 078 191
2023-03-24 $90.01 $91.16 $89.34 $90.74 771 823
2023-03-23 $91.69 $91.69 $89.35 $90.11 1 244 800
2023-03-22 $92.25 $92.25 $89.98 $90.08 963 168
2023-03-21 $92.24 $92.82 $91.77 $92.08 1 581 097
2023-03-20 $92.07 $93.76 $91.23 $92.34 1 201 310
2023-03-17 $92.37 $92.45 $90.49 $91.67 1 757 429
2023-03-16 $87.45 $93.63 $87.34 $93.41 2 829 181
2023-03-15 $89.25 $89.64 $87.52 $87.74 1 512 192
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT